MYP_140157
MIP(M11A)
Anticancer
Anticancer
▸
Antitumor
Anticancer
▸
Cytotoxic anticancer activity
▸
Cytotoxic
Antimicrobial
Toxicity / Safety
▸
Blood cell toxicity
▸
Hemolysis
▸
Hemolytic
Toxicity / Safety
▸
Cytotoxicity
▸
Cytotoxic
Venom / Toxin
▸
General toxin
▸
Cytotoxic
Standard
12 amino acids
C82H112N20O18
Standard
PRFWEYWLRLAE
1665.89 Da
6.70
-0.03
-0.10
-0.0026
-0.71
0.79
-0.05
20.57
73.33
0.3333
12490.00
12490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Amino Acid Composition
619.64
0.16
24.0
18.0
49.0
120.0
7.0
11.0
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
RECORD: Rec_0068370
VERIFIED: YES
Provenance & Taxonomy
E3 ubiquitin-protein ligase [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial
Anticancer
Cytotoxic
RECORD: Rec_0076114
VERIFIED: NO
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Anticancer
RECORD: Rec_0099990
VERIFIED: YES
Provenance & Taxonomy
E3 ubiquitin-protein ligase [other]
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial
Anticancer
--
IC50
RECORD: Rec_0374945
VERIFIED: YES
Provenance & Taxonomy
not reported [other]
Structure & Mods
linear peptide; DSSP H 0.0%, E 0.0%, T 66.7%, C 33.3% [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Anticancer
Antitumor
RECORD: Rec_0378517
VERIFIED: YES
Provenance & Taxonomy
Homo sapiens [Animal]
E3 ubiquitin-protein ligase
9606
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Anticancer
Cytotoxic
HCT-116-p53+/+
0.4 μM
IC50
Showing 5 records on this page · Page 1 of 2